Clinically evident polyvascular disease and regression of coronary atherosclerosis after intensive statin therapy in patients with acute coronary syndrome: serial intravascular ultrasound from the Japanese assessment of pitavastatin and atorvastatin in acute coronary syndrome (JAPAN-ACS) trial.

[1]  C. Suárez,et al.  Prognostic value of the ankle‐brachial index in elderly patients with a stable chronic cardiovascular event , 2010, Journal of thrombosis and haemostasis : JTH.

[2]  M. Matsuzaki,et al.  Diabetes mellitus is a major negative determinant of coronary plaque regression during statin therapy in patients with acute coronary syndrome--serial intravascular ultrasound observations from the Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome Trial (the JAPAN-ACS Tria , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[3]  W. Tracz,et al.  The role of carotid intima-media thickness assessment in cardiovascular risk evaluation in patients with polyvascular atherosclerosis. , 2010, Atherosclerosis.

[4]  A. Neskovic,et al.  The prevalence of polyvascular disease in patients referred for peripheral arterial disease. , 2009, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[5]  Katsumi Miyauchi,et al.  Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin , 2009, Journal of the American College of Cardiology.

[6]  G. Dangas,et al.  Prevalence and prediction of previously unrecognized peripheral arterial disease in patients with coronary artery disease: The peripheral arterial disease in Interventional Patients Study , 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[7]  Deepak L. Bhatt,et al.  Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes. , 2009, European heart journal.

[8]  Gert Mayer,et al.  Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. , 2009, The New England journal of medicine.

[9]  Spence M. Taylor.  Commentary. Gaps in public knowledge of peripheral arterial disease: The first national PAD public awareness survey. , 2008, Perspectives in vascular surgery and endovascular therapy.

[10]  E. Tuzcu,et al.  Effect of diabetes on progression of coronary atherosclerosis and arterial remodeling: a pooled analysis of 5 intravascular ultrasound trials. , 2008, Journal of the American College of Cardiology.

[11]  Jeroen J. Bax,et al.  Long-term prognosis of patients with peripheral arterial disease: a comparison in patients with coronary artery disease. , 2008, Journal of the American College of Cardiology.

[12]  M. Criqui,et al.  Gaps in Public Knowledge of Peripheral Arterial Disease: The First National PAD Public Awareness Survey , 2007, Circulation.

[13]  Deepak L. Bhatt,et al.  Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. , 2007, Journal of the American College of Cardiology.

[14]  Deepak L. Bhatt,et al.  One-year cardiovascular event rates in outpatients with atherothrombosis. , 2007, JAMA.

[15]  C. Cimminiello,et al.  Low ankle–brachial index predicts an adverse 1‐year outcome after acute coronary and cerebrovascular events , 2006, Journal of thrombosis and haemostasis : JTH.

[16]  Deepak L. Bhatt,et al.  The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials. , 2006, Journal of the American College of Cardiology.

[17]  J. Allenberg,et al.  Association of low ankle brachial index with high mortality in primary care. , 2006, European heart journal.

[18]  K. Harjai,et al.  Usefulness of the presence of peripheral vascular disease in predicting mortality in acute myocardial infarction patients treated with primary angioplasty (from the Primary Angioplasty in Myocardial Infarction Database). , 2005, The American journal of cardiology.

[19]  J. Knottnerus,et al.  Asymptomatic peripheral arterial occlusive disease predicted cardiovascular morbidity and mortality in a 7-year follow-up study. , 2004, Journal of clinical epidemiology.

[20]  E. Topol,et al.  Peripheral vascular disease and one-year mortality following percutaneous coronary revascularization. , 2003, The American journal of cardiology.

[21]  B. Lewis,et al.  Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 stu , 2003, American heart journal.

[22]  M. Hori,et al.  Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: an angioscopic study. , 2001, Journal of the American College of Cardiology.

[23]  C. Tracy,et al.  American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. , 2001, Journal of the American College of Cardiology.

[24]  N. Powe,et al.  Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[25]  D. Tanné,et al.  Prognostic significance of cerebrovascular disease in 11,526 chronic coronary artery disease patients. Bezafibrate Infarction Prevention (BIP) Study Group. , 1998, The American journal of cardiology.

[26]  M. A. Sellers,et al.  Long-term prognostic value of clinically evident noncoronary vascular disease in patients undergoing coronary revascularization in the Bypass Angioplasty Revascularization Investigation (BARI). , 1998, The American journal of cardiology.

[27]  J. Tobis,et al.  Identification of coronary thrombus after myocardial infarction by intracoronary ultrasound compared with histology of tissues sampled by atherectomy. , 1996, The American journal of cardiology.

[28]  B. Gersh,et al.  Long-term survival in patients with coronary artery disease: Importance of peripheral vascular disease , 1994 .

[29]  R. Langer,et al.  Mortality over a period of 10 years in patients with peripheral arterial disease. , 1992, The New England journal of medicine.

[30]  J. Guindo,et al.  Usefulness of an abnormal ankle-brachial index for detecting multivessel coronary disease in patients with acute coronary syndrome. , 2010, Revista espanola de cardiologia.

[31]  Iñaki Lekuona,et al.  Utilidad de un índice tobillo-brazo patológico en la identificación de la enfermedad coronaria multivaso en pacientes con síndrome coronario agudo , 2010 .

[32]  M. Davidović,et al.  Progression of polyvascular disease--is there any rule? , 2008, Advances in gerontology = Uspekhi gerontologii.

[33]  M. Criqui,et al.  Peripheral arterial disease detection, awareness, and treatment in primary care. , 2001, JAMA.

[34]  B. Gersh,et al.  Long-term survival in patients with coronary artery disease: importance of peripheral vascular disease. The Coronary Artery Surgery Study (CASS) Investigators. , 1994, Journal of the American College of Cardiology.